In contrast, utilizing ANP to pharmacologically activate the ANP-GC-A pathway is unlikely to result in toxicity to organisms since activation of the ANP-GC-A pathway did not have an impact on lung gene expression in the absence of cancer cells (Figures 2–4). The gene discussed is GCA; the disease is cancer.